Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Eibach D < Eichelberger M < Eichenberger E

M Eichelberger
NONE (BIBLIO)
000054
000055
000174
000344
000425
000435
000C15
M. C. Eichelberger
NONE (BIBLIO)
000039
000077
000284
000881
000E69
M. Eichelberger
NONE (BIBLIO)
000079
000548
000715
000A61
M.C. Eichelberger
NONE (BIBLIO)
000079
000153
000192
000312
000313
000410
000715
000A61
MC Eichelberger
NONE (BIBLIO)
000017
000054
000100
000168
000174
000181
000328
000344
000435
000447
000456
000582
000596
000666
000735
000736
000873
000A16
000A20
000A72
000E68
000E88
000F11
001141
Maryna C. Eichelberger
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA
États-Unis
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland
Maryland
000A24
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
États-Unis
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993
Maryland
000184
Division of Biological Standards and Quantity Control, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
États-Unis
Division of Biological Standards and Quantity Control, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993
Maryland
000034
Division of Viral Products, Center for Biologics Evaluation and Research,Food and Drug Administration, Bethesda, MD 20892;
États-Unis
Maryland
, Bethesda
000C77
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
États-Unis
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
Maryland
000174
Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration,Silver Spring, Maryland;
000272

000C56
Maryna Eichelberger
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
États-Unis
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993
Maryland
000539
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
États-Unis
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
Maryland
000344

<g>
<k>Eichelberger M</k>
<l>
<g>
<k>M Eichelberger</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000054</i>
<i>000055</i>
<i>000174</i>
<i>000344</i>
<i>000425</i>
<i>000435</i>
<i>000C15</i>
</l>
<n>7</n>
<t>7</t>
</g>
</l>
<n>1</n>
<t>7</t>
</g>
<g>
<k>M. C. Eichelberger</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000039</i>
<i>000077</i>
<i>000284</i>
<i>000881</i>
<i>000E69</i>
</l>
<n>5</n>
<t>5</t>
</g>
</l>
<n>1</n>
<t>5</t>
</g>
<g>
<k>M. Eichelberger</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000079</i>
<i>000548</i>
<i>000715</i>
<i>000A61</i>
</l>
<n>4</n>
<t>4</t>
</g>
</l>
<n>1</n>
<t>4</t>
</g>
<g>
<k>M.C. Eichelberger</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000079</i>
<i>000153</i>
<i>000192</i>
<i>000312</i>
<i>000313</i>
<i>000410</i>
<i>000715</i>
<i>000A61</i>
</l>
<n>8</n>
<t>8</t>
</g>
</l>
<n>1</n>
<t>8</t>
</g>
<g>
<k>MC Eichelberger</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000017</i>
<i>000054</i>
<i>000100</i>
<i>000168</i>
<i>000174</i>
<i>000181</i>
<i>000328</i>
<i>000344</i>
<i>000435</i>
<i>000447</i>
<i>000456</i>
<i>000582</i>
<i>000596</i>
<i>000666</i>
<i>000735</i>
<i>000736</i>
<i>000873</i>
<i>000A16</i>
<i>000A20</i>
<i>000A72</i>
<i>000E68</i>
<i>000E88</i>
<i>000F11</i>
<i>001141</i>
</l>
<n>24</n>
<t>24</t>
</g>
</l>
<n>1</n>
<t>24</t>
</g>
<g>
<k>Maryna C. Eichelberger</k>
<l>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="A2">Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>000A24</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="A5">Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>000184</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="A6">Division of Biological Standards and Quantity Control, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Biological Standards and Quantity Control, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>000034</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="aff1">Division of Viral Products, Center for Biologics Evaluation and Research,
<institution>Food and Drug Administration</institution>
, Bethesda, MD 20892;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>, Bethesda</wicri:cityArea>
</affiliation>
</k>
<l>
<i>000C77</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="aff5">
<addr-line>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>000174</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>
<nlm:aff id="AF0003">
<institution>Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration</institution>
,
<addr-line>Silver Spring, Maryland</addr-line>
;</nlm:aff>
</affiliation>
</k>
<l>
<i>000272</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</k>
<l>
<i>000C56</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>7</n>
<t>7</t>
</g>
<g>
<k>Maryna Eichelberger</k>
<l>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="A2">Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>000539</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="2">
<nlm:aff id="aff4">
<addr-line>Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA</addr-line>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</k>
<l>
<i>000344</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>7</n>
<t>57</t>
</g>

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021